Europe’s STOXX 600 falls as tech, healthcare shares drag
Europe's STOXX 600 fell on Friday, dragged by technology and healthcare stocks, keeping the index on track for its fourth ...
GlobalData on MSN1d
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Regeneron, Sanofi Get New FDA Review of Dupixent for CSU
The FDA last year turned away the companies' application and asked for additional efficacy data. Regeneron and Sanofi said the resubmission adds results from an additional Phase 3 study of Dupixent in ...
Unilever explores sale of Dutch brands like Unox, Conimex, sources say
Unilever is exploring the sale of some of its Dutch food brands, three sources with knowledge of the process said, as part of ...
Are Established Consumer Brands Dying? Part I: Nestlé
Nestlé (NSRGY) has seen large, "recession-type" stock price declines whilst the market has been rising. Read why I'm neutral ...
Seeking Alpha3d
Sanofi: Diverse Drug Portfolio And Future Pipeline, 4% Dividend Yield Looks Attractive
Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...